CTRI/2023/02/049881招募中未知
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single oral dose, crossover, bioequivalence study of Mini XL 5mg tablet (Prazosin 5 mg ER tablet) of The ACME Laboratories Ltd., in comparison with Minipressï?¢ XL 5mg tablet (Prazosin 5 mg ER tablet) of M/S. Fareva Amboise in healthy, adult, human subjects under fasting condition. - NI
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Ba/be
入排标准
入选标准
- •1. Able to comprehend the nature and purpose of the study and willing to give written informed consent for participation in the study
- •2. Willing to be available for the entire study period and to comply with protocol requirements.
- •3. Normal, healthy, adult, human subject of 18-45 years (both inclusive) of age.
- •4. Body mass index in the range of 18 â?? 30 kg/m2 (both inclusive).
排除标准
- •1. Any medical or surgical condition, which might significantly interfere with the functioning of the gastrointestinal tract or bloodâ??forming organs.
- •2. History or presence of gastric or duodenal ulcer or GI bleeding or blood in stools anytime in the past.
- •3. History of severe infection or major surgery in the past 6 months.
- •4. History of Minor surgery or fracture within the past 3 months.
研究者
相似试验
尚未招募
不适用
Comparative bioavailability study of Test product Alogliptin and Pioglitazone tablets 12.5 mg/45 mg compared with the reference product of Oseni (alogliptin and pioglitazone) tablets 12.5 mg/ 45 mg, in healthy, adult, human subjects, under fed conditions.CTRI/2019/04/018646Indoco Remedies Limited
招募中
不适用
To compare Bioequivalence study of Sitagliptin 100 mg Metformin Hydrochloride 1000 mg extended release Tablets in healthy adult human subjects under fasting conditionsCTRI/2023/02/049858SunGlow Lifescience Private Ltd
尚未招募
不适用
Comparative bioavailability study of Test product Fesoterodine Fumarate ER Tablets 8 mg compared with the reference product of Toviaz® (fesoterodine fumarate) Extended-Release Tablets 8 mg, in healthy, adult, human subjects, under fasting conditions.CTRI/2019/04/018645MSN Laboratories Private Limited
进行中（未招募）
Unknown
Bioequivalence study of Esomeprazole 20 mg Naproxen 500 mg Delayed Release Tablets in healthy adult human subjects under fasting conditioCTRI/2023/04/051767Faromed Lifesciences LLP (Subsidiary of Omnicals Pharma Private Limited)
尚未招募
不适用
Comparative bioavailability study of Test product Fesoterodine Fumarate ER Tablets 8 mg compared with the reference product of Toviaz® (fesoterodine fumarate) Extended-Release Tablets 8 mg, in healthy, adult, human subjects, under fed conditions.CTRI/2019/04/018644MSN Laboratories Private Limited